France’s Orano group announced that Orano Projets has acquired a majority stake in CERIS Group, which operates in the healthcare and life science sectors “as well as in industries subject to severe constraints”.
This acquisition will enable Orano Projets to accelerate the development of complementary know-how and new locations, in particular in Nantes and Lyon where CERIS Group is already established. Orano Projets will also benefit from a broadened product and service offering in the field of engineering, design and construction for industrial projects in the healthcare-pharmaceuticals and biotechnology sectors.
CERIS Group employs around 50 people in France. Orano Projets, with 1600 employees worldwide, will strengthen CERIS Group's capacity to respond to its customers' large-scale projects, whether for design and construction phases, service provision or complete turnkey projects, Orano said.
CERIS Group, specialising in engineering and consulting services, is organised by business line around three subsidiaries: CERIS Ingénierie, Elix and CERIS Architecture. These subsidiaries operate in sectors, including pharmaceuticals and biotechnology, hospitals and nuclear medicine, as well as supporting laboratories and other industries subject to severe constraints or highly controlled environments (microelectronics, cosmetics, etc).
